233 related articles for article (PubMed ID: 30292871)
1. Clinical significance of aberrant cyclin-dependent kinase-like 2 methylation in hepatocellular carcinoma.
Zhou Y; Qiu XP; Li ZH; Zhang S; Rong Y; Yang GH; Fang-Zheng
Gene; 2019 Jan; 683():35-40. PubMed ID: 30292871
[TBL] [Abstract][Full Text] [Related]
2. Aberrant methylation of TRIM58 in hepatocellular carcinoma and its potential clinical implication.
Qiu X; Huang Y; Zhou Y; Zheng F
Oncol Rep; 2016 Aug; 36(2):811-8. PubMed ID: 27373520
[TBL] [Abstract][Full Text] [Related]
3. Promoter aberrant methylation status of
Chen G; Fan X; Li Y; He L; Wang S; Dai Y; Bin C; Zhou D; Lin H
Epigenetics; 2020; 15(6-7):684-701. PubMed ID: 31933413
[TBL] [Abstract][Full Text] [Related]
4. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
Li Z; Zhang H; Yang J; Hao T; Li S
Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295
[TBL] [Abstract][Full Text] [Related]
5. CHD5 a tumour suppressor is epigenetically silenced in hepatocellular carcinoma.
Zhao R; Wang N; Huang H; Ma W; Yan Q
Liver Int; 2014 Jul; 34(6):e151-60. PubMed ID: 24529164
[TBL] [Abstract][Full Text] [Related]
6. Methylation of IRAK3 is a novel prognostic marker in hepatocellular carcinoma.
Kuo CC; Shih YL; Su HY; Yan MD; Hsieh CB; Liu CY; Huang WT; Yu MH; Lin YW
World J Gastroenterol; 2015 Apr; 21(13):3960-9. PubMed ID: 25852282
[TBL] [Abstract][Full Text] [Related]
7. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.
Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W
Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823
[TBL] [Abstract][Full Text] [Related]
8. Hypermethylation of ACP1, BMP4, and TSPYL5 in Hepatocellular Carcinoma and Their Potential Clinical Significance.
Qiu X; Hu B; Huang Y; Deng Y; Wang X; Zheng F
Dig Dis Sci; 2016 Jan; 61(1):149-57. PubMed ID: 26386860
[TBL] [Abstract][Full Text] [Related]
9. Decreased Expression of BNC1 and BNC2 Is Associated with Genetic or Epigenetic Regulation in Hepatocellular Carcinoma.
Wu Y; Zhang X; Liu Y; Lu F; Chen X
Int J Mol Sci; 2016 Jan; 17(2):. PubMed ID: 26821013
[TBL] [Abstract][Full Text] [Related]
10. Aberrant CpG island hypermethylation and down-regulation of Oct-6 mRNA expression in human hepatocellular carcinoma.
Sun JZ; Yang XX; Li XH; Xu WW; Wang Y; Zhu W; Li M
Dig Dis Sci; 2011 Oct; 56(10):3072-7. PubMed ID: 21448695
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic silencing of TMEM176A activates ERK signaling in human hepatocellular carcinoma.
Li H; Zhang M; Linghu E; Zhou F; Herman JG; Hu L; Guo M
Clin Epigenetics; 2018 Nov; 10(1):137. PubMed ID: 30400968
[TBL] [Abstract][Full Text] [Related]
12.
Anwar SL; Krech T; Hasemeier B; Schipper E; Schweitzer N; Vogel A; Kreipe H; Buurman R; Skawran B; Lehmann U
World J Gastroenterol; 2017 Mar; 23(9):1568-1575. PubMed ID: 28321157
[TBL] [Abstract][Full Text] [Related]
13. Aberrant TIG1 methylation associated with its decreased expression and clinicopathological significance in hepatocellular carcinoma.
Chen XH; Wu WG; Ding J
Tumour Biol; 2014 Feb; 35(2):967-71. PubMed ID: 24006221
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus X protein promotes P3 transcript expression of the insulin-like growth factor 2 gene via inducing hypomethylation of P3 promoter in hepatocellular carcinoma.
Tang S; Hu W; Hu J; Wu S; Li J; Luo Y; Cao M; Zhou H; Jiang X
Liver Int; 2015 Feb; 35(2):608-19. PubMed ID: 24423280
[TBL] [Abstract][Full Text] [Related]
15. Methylation status of genes upregulated by demethylating agent 5-aza-2'-deoxycytidine in hepatocellular carcinoma.
Hirasawa Y; Arai M; Imazeki F; Tada M; Mikata R; Fukai K; Miyazaki M; Ochiai T; Saisho H; Yokosuka O
Oncology; 2006; 71(1-2):77-85. PubMed ID: 17341888
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D receptor gene methylation in hepatocellular carcinoma.
Abdalla M; Khairy E; Louka ML; Ali-Labib R; Ibrahim EA
Gene; 2018 May; 653():65-71. PubMed ID: 29432829
[TBL] [Abstract][Full Text] [Related]
17. Identification of a non-coding KLF4 transcript generated from intron retention and downregulated in human hepatocellular carcinoma.
Zhou J; Lai PB; Tsui SK
Int J Oncol; 2015 Oct; 47(4):1554-62. PubMed ID: 26238073
[TBL] [Abstract][Full Text] [Related]
18. [BORIS Regulates SOCS3 Expression Through Epigenetic Mechanisms in Human Hepatocellular Carcinoma Cells].
He JY; Liu QY; Wei L; Liu ZJ; Huang Y; Yu XQ; Li B; Qin Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 49(1):1-7. PubMed ID: 29737080
[TBL] [Abstract][Full Text] [Related]
19. Hypermethylation leads to bone morphogenetic protein 6 downregulation in hepatocellular carcinoma.
He Y; Cui Y; Xu B; Gu J; Wang W; Luo X
PLoS One; 2014; 9(1):e87994. PubMed ID: 24498236
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of hDAB2IPA and hDAB2IPB in normal tissues and promoter methylation of hDAB2IPA in hepatocellular carcinoma.
Qiu GH; Xie H; Wheelhouse N; Harrison D; Chen GG; Salto-Tellez M; Lai P; Ross JA; Hooi SC
J Hepatol; 2007 Apr; 46(4):655-63. PubMed ID: 17258345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
